This is the text extract for October Tender Notification., browse documents here.

---

29 October 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products included in the Invitation to Tender dated 23 December 2008 and the Invitation to Tender dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th November 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2008/09 Tender Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where an alternative brand is already listed – listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 December 2010; Hospital Supply Status and DV Limits will apply from 1 February 2011; delisting of the other brand in Section H will occur on 1 February 2011.

The decisions were as follows:

Chemical Name Dopamine hydrochoride

Presentation; Pack size and type Inj 40 mg per ml, 5 ml; 10 ampoules

Hospital Supply Brand (Supplier) Max Health

Current New pack DV pack price price Limit $54.00 (per 5) $82.08 (per 10) 1%

Brand (Supplier) to be delisted Mayne (Hospira)

2009/10 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 2. Tenders awarded to an unlisted pharmaceutical – listing of the tender winning brand will occur in on 1 December 2010 and Sole Supply Status commences 1 March 2011.

The decisions were as follows:

Chemical Name Escitalopram Escitalopram Sertraline

Presentation; Pack size and type Tab 10 mg; 28 tablets, blister pack Tab 20 mg; 28 tablets, blister pack Tab 50 mg; 90 tablets, blister pack

Price and subsidy $2.65 $4.20 $5.40

Sole supply brand (Supplier) Loxalate (Mylan) Loxalate (Mylan) Arrow-Sertraline (Arrow)

A370871 - qA15909

---

Chemical Name Sertraline

Presentation; Pack size and type Tab 100 mg; 90 tablets, blister pack

Price and subsidy $9.60

Sole supply brand (Supplier) Arrow-Sertraline (Arrow)

3. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (or subsidy reduction) for tender winning brand at the tender subsidy will occur on 1 December 2010, reference pricing of non-tender winning brand will occur on 1 February 2011 and Sole Subsidised Supply commences on 1 May 2011.

The decisions were as follows:

Chemical Name Cefaclor monohydrate Itraconazole

Presentation; Pack size and type Cap 250 mg; 100 capsules, blister pack Cap 100 mg; 15 capsules, blister pack

Current price and subsidy $28.90 $23.70

New price Brand (supplier) Sole supply brand and affected by reference (Supplier) subsidy pricing and delisting $24.57 $4.25 Cefaclor Sandoz (Sandoz) Itrazole (Mylan) Ranbaxy-Cefaclor (Douglas) Sporanox (Janssen-Cilag)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 4. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 December 2010; Hospital Supply Status and DV Limits will apply from 1 February 2011.

The decisions were as follows:

Chemical Name Escitalopram Escitalopram Sertraline Sertraline

Presentation; Pack size and type Tab 10 mg; 28 tablets, blister pack Tab 20 mg; 28 tablets, blister pack Tab 50 mg; 90 tablets, blister pack Tab 100 mg; 90 tablets, blister pack

Price $2.65 $4.20 $5.40 $9.60

Hospital Supply Brand (Supplier) Loxalate (Mylan) Loxalate (Mylan) Arrow-Sertraline (Arrow) Arrow-Sertraline (Arrow)

DV Limit 1% 1% 1% 1%

5. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 December 2010; Hospital Supply Status and DV Limits will apply from 1 February 2011.

The decisions were as follows:

Chemical Name Doxorubicin* Doxorubicin* Doxorubicin*

Presentation; Pack size and type Inj 10 mg; 1 vial Inj 50 mg; 1 vial Inj 100 mg; 1 vial

Current price $8.80 $39.40 $81.00

New price $10.00 $40.00 $80.00

Hospital Supply Brand (Supplier) Doxorubicin Ebewe (InterPharma) Doxorubicin Ebewe (InterPharma) Doxorubicin Ebewe (InterPharma)

DV Limit 1% 1% 1%

A370871 - qA15909

Page 2 of 3

---

Chemical Name Doxorubicin*

Presentation; Pack size and type Inj 200 mg; 1 vial

Current price $162.00

New price $150.00

Hospital Supply Brand (Supplier) Doxorubicin Ebewe (InterPharma)

DV Limit 1%

*The price and subsidy of doxorubicin (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 December 2010. The subsidy for doxorubicin 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.87 per mg to $0.88 per mg from 1 December 2010.

6. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price change for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 December 2010; Hospital Supply Status and DV Limits will apply from 1 February 2011; delisting of the other brand in Section H will occur on 1 February 2011.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Cap 250 mg; 100 capsules, blister pack Cap 100 mg; 15 capsules, blister pack

Current price

New price

Hospital Supply Brand (Supplier) Cefaclor Sandoz (Sandoz) Itrazole (Mylan)

DV Limit 1%

Brand (supplier) to be delisted RanbaxyCefaclor (Douglas) Sporanox (JanssenCilag)

Cefaclor monohydrate

$28.90

$24.57

Itraconazole

$23.70

$4.25

1%

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Amphotericin B Etoposide

Line Item Lipid complex Inj 20 mg per ml, 5 ml

The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 4 December 2009.

The decisions were as follows:

Chemical Name Tacrolimus Tacrolimus Tacrolimus

Line Item Cap 0.5 mg Cap 1 mg Cap 5 mg

For the remaining products on the Invitation to Tender dated 23 December 2008 and the Invitation to Tender dated 4 December 2009 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A370871 - qA15909 Page 3 of 3